Biogen to Build Denmark Plant

Published July 2001

HILLEROD, DENMARK -

Biogen Inc. of Cambridge, Mass., plans to build a $350-million factory in Denmark to produce cell cultures for proteins and process the multiple sclerosis drug Avonex. Construction is slated to begin in 2002.  Copyright 2008 Tradeline Inc.
All Rights Reserved
ISSN: 1096-4894